• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBII:SW

2,934.86 CHF 0.000.00%

As of 10:58:00 ET on 09/18/2014.

Snapshot for Adamant Global Biotech (ADGLBII)

Year To Date: +34.59% 3-Month: +15.30% 3-Year: +46.13% 52-Week Range: 1,908.85 - 2,947.75
1-Month: +6.03% 1-Year: +35.87% 5-Year: - Beta vs SMI: 1.06

Mutual Fund Chart for ADGLBII

No chart data available.
  • ADGLBII:SW 2,934.86
  • 1M
  • 1Y
Interactive ADGLBII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADGLBII

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBII

NAV (on 2014-09-18) 2,934.86
Assets (M) (on 2014-09-18) 138.60
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment -

Dividends for ADGLBII

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBII

Front Load 1.20
Back Load 1.00
Current Mgmt Fee 1.20
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.24

Top Fund Holdings for ADGLBII

Filing Date: 05/30/2014
Name Position Value % of Total
Biogen Idec Inc 38,000 10,849,031 10.168%
Gilead Sciences Inc 140,000 10,163,675 9.526%
Regeneron Pharmaceuticals Inc 35,000 9,604,241 9.001%
Amgen Inc 90,000 9,332,033 8.746%
Celgene Corp 126,000 8,618,474 8.077%
Alexion Pharmaceuticals Inc 41,000 6,095,952 5.713%
Vertex Pharmaceuticals Inc 85,000 5,490,730 5.146%
Illumina Inc 35,000 4,951,366 4.640%
Mylan Inc/PA 106,000 4,722,774 4.426%
ProShares Ultra Nasdaq Biotech 60,000 4,332,260 4.060%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil